Power Law company profile

Xaira Therapeutics

Biotech & Life Sciences · Brisbane, United States · Founded 2023 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$2.5–5B

Latest valuation · 2026

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Investors

15 investors on Xaira Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 15 investors entered at this stage

Lux Capital

University of Washington Institute for Protein Design

Parker Institute for Cancer Immunotherapy

NEA

Sequoia

Menlo Ventures

ARCH Venture Partners

Lightspeed Venture Partners

F-Prime

SV Angel

Byers Capital

Global footprint

Where Xaira Therapeutics has talent and traffic

AI talent share

5.5% of workforce is AI talent
(11 of 200 staff)

Core AI115.5%

Other AI00%

Non-AI workforce18994.5%

Web traffic by country

24K monthly visits
across markets

🇺🇸 United States71.3%

🇨🇦 Canada9.2%

🇯🇵 Japan6.3%

🇮🇳 India5.4%

🇬🇧 United Kingdom5%

Top 5 markets shown

See Xaira Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo